ПОВ 4 оранж новый
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>ПОВ</strong>ОЛЖСКИЙ<br />
ОНКОЛОГИЧЕСКИЙ<br />
ВЕСТНИК 4(31)’2017<br />
associated clones in myelodysplastic syndromes //<br />
Br. J. Haematol. — 2001. — 114 (3). — P. 731-733.<br />
12. Iwanaga M., Furukawa K., Amenomori T. et al.<br />
Paroxysmal nocturnal haemoglobinuria clones<br />
in patients with myelodysplastic syndromes //<br />
Br. J. Haematol. — 1998. — 102 (2). — P. 465-474.<br />
13. Hillmen P., Lewis S.M., Bessler M. et al. Natural history<br />
of paroxysmal nocturnal hemoglobinuria // N. Eng. J.<br />
Med. — 1995. — 333. — P. 1253-1258.<br />
14. DeLatour R.P., Mary J.Y., Salanoubat C. et al. Paroxysmal<br />
nocturnal hemoglobinuria: natural history of<br />
disease subcategories // Blood. — 2008. — 112. —<br />
P. 3099-3106.<br />
15. Muus P., Szer J., Schrezenmeier H., et al. Evaluation<br />
of paroxysmal nocturnal hemoglobinuria disease<br />
burden: the patient’s perspective // Blood. —<br />
2010. — 116. — P. 1525.<br />
16. Hillmen P et al. Long-term effect of the complement<br />
inhibitor eculizumab on kidneyfunction in patients<br />
with paroxysmal nocturnal hemoglobinuria //<br />
Am. J. Hematol. — 2010. — 85. — P. 553-559.<br />
17. Hillmen P. et al. Effect of the complement inhibitor<br />
eculizumab on thromboembolism in patientswith<br />
paroxysmal nocturnal hemoglobinuria // Blood. —<br />
2007. — 110. — P. 4123-4128.<br />
18. Rother R.P., Bell L., Hillmen P., et al. The clinical sequelae<br />
of intravascular hemolysis and extracellular plasma<br />
hemoglobin: a novel mechanism of human disease //<br />
JAMA. — 2005. — 293. — P. 1653-1662.<br />
19. Risitano A.M., Rotoli B. Paroxysmal nocturnal<br />
hemoglobinuria: pathophysiology, natural history<br />
and treatment options in the era of biological<br />
agents // Biologics Targets and Therapy. — 2008. —<br />
2 (2). — P. 205-222.<br />
20. Kim J.S., Jang J.H., Lee J.W., et al. Renal impairment<br />
is a risk factor for early mortality in patients with<br />
paroxysmal nocturnal haemoglobinuria (PNH) //<br />
Haematologica. — 2011. — 96. — P. 112.<br />
21. Borowitz M.J., Craig F.E., DiGiuseppe J.A. et al.<br />
Guidelines for the diagnosis and monitoring of<br />
paroxysmal nocturnal hemoglobinuria and related<br />
disorders by flow cytometry // Cytometry B Clin.<br />
Cytom. — 2010. — 78 (4). — P. 211-230.<br />
22. Кулагин А.Д., Лисуков И.А., Птушкин В.В., и др. Национальные<br />
клинические рекомендации по диагностике<br />
и лечению пароксизмальной ночной<br />
гемоглобинурии // Клин. фармакол. тер. — 2015.<br />
— 24 (1). — С. 18-26.<br />
23. National Comprehensive Cancer Network (NCCN)<br />
Clinical Practice Guidelines in Oncology:<br />
Myelodysplastic syndromes. National Comprehensive<br />
Cancer Network (NCCN), 2010.<br />
24. Santarone S., Bacigalupo A., Risitano A.M., et<br />
al. Hematopoietic stem cell transplantation for<br />
paroxysmal nocturnal hemoglobinuria: Long-term<br />
results of a retrospective study on behalf of the<br />
Gruppo Italiano Trapianto Midollo Osseo (GITMO) //<br />
Haematologica. — 2010. — 95. — P. 983-8.<br />
25. de Latour R.P., Schrezenmeier H., Mary J.-Y.,<br />
Bacigalupo A., et al. Stem cell transplantation<br />
for paroxysmal nocturnal haemoglobinuria: an<br />
ongoing joint study of the AAWP EBMT Group and<br />
the French Society of Haematology // Bone Marrow<br />
Transplantation. — 2009. — 43. — P. S57-S58.<br />
26. Kanakura Y., Ohyashiki K., Shichishima T., et al. Safety<br />
and efficacy of the terminal complement inhibitor<br />
eculizumab in Japanese patients with paroxysmal<br />
nocturnal hemoglobinuria: the AEGIS clinical trial //<br />
Int. J. Hematol. — 2011. — 93. — P. 36-46.<br />
27. Kelly R.J., Hill A., Arnold L.M. et al. Long-term<br />
treatment with eculizumab in paroxysmal nocturnal<br />
hemoglobinuria: sustained efficacy and improved<br />
survival // Blood. — 2011. — 117 (25). — P. 6786-6792.<br />
28. Hall C., Richards S., Hillmen P. Primary prophylaxis<br />
with warfarin prevents thrombosis in paroxysmal<br />
nocturnal hemoglobinuria (PNH) // Blood. — 2003. —<br />
102. — P. 3587-3591.<br />
29. Kelly R.J., Hill A., Arnold L.M., et al. Long-term<br />
treatment with eculizumab in paroxysmal nocturnal<br />
hemoglobinuria: sustained efficacy and improved<br />
survival // Blood. — 2011. — 117 (25). — P. 6786-6792.<br />
30. Loschi M., Porcher R., Barraco F., et al. Impact of<br />
eculizumab treatment on paroxysmal nocturnal<br />
hemoglobinuria: a treatment versus no-treatment<br />
study // Am. J. Hematol. — 2016. — 91 (4). —<br />
P. 366-370.<br />
31. Peffault de Latour R., Schrezenmeier H.,<br />
Bacigalupo A., et al. Allogeneic stem cell<br />
transplantation in paroxysmal nocturnal<br />
hemoglobinuria // Haematologica. — 2012. —<br />
97 (11). — P. 1666-1673.<br />
32. Савченко В.Г., Паровичникова Е.Н., Кохно А.В. и соавт.<br />
Национальные клинические рекомендации<br />
по диагностике и лечению миелодиспластических<br />
синдромов взрослых. — 2015.<br />
Конфликт интересов отсутствует<br />
Г.А. Дудина Влияние клона пароксизмальной ночной гемоглобинурии на прогрессию цитопении ...<br />
89
Change language